Source: CNA
As of Thursday 21/12/2023, the Nuvaxovid HBV.1.5 COVID-19 vaccine by Novavax will be available for people over 18 years of age, the Ministry of Health said in a statement.
As noted, Nuvaxovid can be administered for a baseline vaccination cycle or as a booster dose to people aged 18 years and older after a baseline cycle consisting of an mRNA vaccine or an adenovirus-based vaccine.
Beneficiaries wishing to be vaccinated with the Nuvaxovid vaccine can refer to the vaccination centres operating in all provinces and only following a telephone appointment.
It is noted that arrangements for COVID-19 vaccinations with Pfizer's vaccine, as well as for influenza vaccinations, remain the same (walk-in).
It is recalled that for the vaccine administration, an identification document (identity card, passport, Alien Registration Number) must be presented.
It is added that for persons who have previously been vaccinated against COVID-19, the vaccination may be administered in the 5 months following the last vaccination, while a minimum interval of 3 months should be observed for vaccination against COVID-19 after a positive test for COVID-19.
In case a beneficiary wishes to be vaccinated only with the COVID-19 vaccine or on the same day with both vaccines (for COVID-19 and seasonal influenza), they can refer to the Ministry of Health's Vaccination Centres. Vaccination of non-GHS beneficiaries, who nevertheless belong to the high-risk groups, will be provided free of charge at the Ministry of Health Adult Vaccination Centres.
The vaccination of the General Healthcare System beneficiaries with the seasonal influenza vaccine who belong to the high-risk groups may be carried out by their personal physician by appointment, the statement concludes.
